Schenergix Celebrates a Successful Pharma Pro & Pack Expo 2026

Over the course of the three-day exhibition, the Schenergix engineering and technical sales team engaged in numerous productive discussions with customers looking to modernise pharmaceutical production, improve manufacturing efficiency and adopt the latest continuous processing technologies. The exhibition provided an excellent platform to demonstrate how continuous manufacturing is transforming pharmaceutical production by delivering greater product consistency, improved process control, reduced operating costs and significantly shorter production cycles.

Visitors showed considerable interest in Schenergix's innovative portfolio of continuous blending systems, continuous granulation equipment, Hot Melt Extrusion (HME) systems, continuous powder handling technologies, continuous feeding solutions, process automation, and fully integrated continuous manufacturing lines. Many discussions focused on replacing traditional batch manufacturing with continuous processes capable of improving product quality while increasing manufacturing flexibility and throughput.

A key theme throughout the exhibition was the pharmaceutical industry's increasing investment in continuous manufacturing as a strategic approach to enhancing productivity, reducing waste and achieving greater process reliability. Customers were particularly interested in Schenergix's ability to provide complete process development support, pilot-scale systems, commercial production equipment and fully integrated manufacturing solutions tailored to their formulation and production requirements.

The exhibition also highlighted the advantages of Schenergix being part of the Standard Group of Companies, enabling customers to source complete engineering solutions from a single trusted partner. By combining Schenergix's expertise in continuous processing with the Group's capabilities in process equipment, containment systems, pumps, valves, automation, mechanical seals and turnkey engineering, customers recognised the significant benefits of working with an organisation capable of delivering complete pharmaceutical manufacturing facilities from concept through to commissioning.

The event generated numerous exciting enquiries for new continuous manufacturing projects, formulation development programmes, Hot Melt Extrusion applications and integrated production systems. These opportunities reflect the growing industry confidence in Schenergix's engineering expertise and its commitment to supporting the pharmaceutical industry's transition towards smarter, more efficient manufacturing technologies.

As pharmaceutical manufacturing continues to evolve through digitalisation, automation and continuous processing, Schenergix remains committed to developing innovative engineering solutions that help customers improve product quality, enhance operational efficiency and remain competitive in a rapidly changing global market.

Schenergix would like to sincerely thank everyone who visited Hall 3, Stall C-42 during Pharma Pro & Pack Expo 2026. We greatly appreciate the opportunity to meet both existing customers and new industry partners, exchange technical knowledge and discuss future projects. We look forward to building on the many relationships established during the exhibition and continuing to support the pharmaceutical industry with innovative continuous manufacturing technologies as part of the Standard Group of Companies.